Concepedia

Farooq Wandroo

FW

Statistics

Publications

10

Citations

267

H-Index

10

Active since

2004

Affiliations

Sandwell & West Birmingham Hospitals NHS Trust(Current)

University of Birmingham

Queen Elizabeth Hospital Birmingham

The Royal Wolverhampton NHS Trust

Memorial Sloan Kettering Cancer Center

Farooq Wandroo is an author at Sandwell & West Birmingham Hospitals NHS Trust specializing in medicine, hematologic oncology, and cancer immunology.

ORCID

Publications per year

2004–2024

10

Publications

10

Mogamulizumab <i>versus</i> investigator’s choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma

Adrienne A. Phillips, Paul Fields, Olivier Hermine et al. · Haematologica · 2018 · 68 citations · Full text

, , +17

Real-world outcomes of newly diagnosed AML treated with venetoclax and azacitidine or low-dose cytarabine in the UK NHS

Jad Othman, Ho Pui Jeff Lam, Sarah Leong et al. · Blood Neoplasia · 2024 · 36 citations · Full text

, , +11

Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia

Helen Parry, Graham McIlroy, Rachel Bruton et al. · Journal of Hematology & Oncology · 2022 · 35 citations · Full text

, , +17

South Asian chronic lymphocytic leukaemia patients have more rapid disease progression in comparison to White patients

Chaminda Gunawardana, Belinda Austen, Judith E. Powell et al. · British Journal of Haematology · 2008 · 29 citations

, , +16

Real‐world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study

Dragana Milojković, Nicholas C.P. Cross, Sahra Ali et al. · British Journal of Haematology · 2020 · 29 citations · Full text

, , +13

1–5 of 10